Abstract
Aromatase inhibitors (Ais) are used as adjuvant endocrine therapy for oestrogen receptor-positive (ER+ve) post-menopausal breast cancer patients. Ais,......
小提示：本篇文献需要登录阅读全文，点击跳转登录
Full Text Link
